NCT04195633
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +59 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Lymphoma, B-Cell, Marginal Zone
Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.
645 public trials
88 recruiting studies
Lymphoma, B-Cell, Marginal Zone trial results
NCT07387471
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 279178 Nagoya, Aichi-ken, Japan
- Nagoya City University Hospital /ID# 277580 Nagoya, Aichi-ken, Japan
- University of Fukui Hospital /ID# 279173 Yoshida-gun, Fukui, Japan
- Kyushu University Hospital /ID# 277582 Fukuoka, Japan
NCT07554898
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- No. 1, East Banshan Road , Gongshu District Hangzhou, Zhejiang, China
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT06149286
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States
- Indiana University and Comprehensive Cancer Center Indianapolis, Indiana, United States
- Hattiesburg Clinic Hattiesburg, Mississippi, United States
Recruiting
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
NCT07249905
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DLBCL - Diffuse Large B Cell Lymphoma, +28 more
- Locations
-
- Epworth HealthCare Richmond, Victoria, Australia
- Linear Clinical Research Nedlands, Western Australia, Australia
NCT06859008
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +39 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT05294731
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +36 more
- Locations
-
- The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
- Anhui Provincial Hospital Hefei, Anhui, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Chao Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
NCT04491370
- Conditions
- B-cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +27 more
- Locations
-
- New York Medical Center Valhalla, New York, United States
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
- Locations
-
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
NCT06533579
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
- Locations
-
- City of Hope Duarte, California, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- New York Medical College Valhalla, New York, United States